These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31058560)

  • 21. Obesity may influence the relationship between sex hormones and lower urinary tract symptoms.
    Antunes AA; Araújo LH; Nakano E; Muracca E; Srougi M
    Int Braz J Urol; 2014; 40(2):240-6. PubMed ID: 24856492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Body Mass Index and Risk of Prostate Volume, International Prostate Symptom Score, Maximum Urinary Flow Rate, and Post-Void Residual in Benign Prostatic Hyperplasia Patients.
    Li BH; Deng T; Huang Q; Zi H; Weng H; Zeng XT
    Am J Mens Health; 2019; 13(4):1557988319870382. PubMed ID: 31426706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between body mass index and prostate volume in benign prostatic hyperplasia patients undergoing holmium enucleation of the prostate surgery.
    Batai K; Phung M; Bell R; Lwin A; Hynes KA; Price E; Meiklejohn KM; Bracamonte ER; Funk JT
    BMC Urol; 2021 Jun; 21(1):88. PubMed ID: 34112139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum total and bioavailable testosterone levels, central obesity, and muscle strength changes with aging in healthy Chinese men.
    Chu LW; Tam S; Kung AW; Lo S; Fan S; Wong RL; Morley JE; Lam KS
    J Am Geriatr Soc; 2008 Jul; 56(7):1286-91. PubMed ID: 18482300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.
    Ozden C; Ozdal OL; Urgancioglu G; Koyuncu H; Gokkaya S; Memis A
    Eur Urol; 2007 Jan; 51(1):199-203; discussion 204-6. PubMed ID: 16806666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous testosterone as a predictor of prostate growing disorders in the aging male.
    Porcaro AB; Amigoni N; Tafuri A; Rizzetto R; Shakir A; Tiso L; Cerrato C; Lacola V; Antoniolli SZ; Gozzo A; Odorizzi K; Brunelli M; Migliorini F; Artibani W; Cerruto MA; Siracusano S; Antonelli A
    Int Urol Nephrol; 2021 May; 53(5):843-854. PubMed ID: 33389506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence and risk factors of prostatic calculi in Han Chinese: a cross-sectional study based on health examinations.
    Meng J; Zhang M; Guan SY; Zhou J; Fan S; Hu H; Liang C
    Aging Male; 2020 Dec; 23(5):887-892. PubMed ID: 31156012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatty liver index is associated with the risk of testosterone deficiency in aging men without metabolic syndrome.
    Liu CC; Huang SP; Hsieh TJ; Lee CH; Cheng KH; Huang TY; Geng JH; Li CC; Wu WJ; Lee YC
    Andrology; 2021 May; 9(3):863-872. PubMed ID: 33484089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Prostate Specific Antigen and Testosterone Hormone Levels in Patients of Benign Prostatic Hyperplasia in Khartoum State-Sudan.
    A M Alameen A; A M Osman T; A Elissidig S; Atif M
    Pak J Biol Sci; 2020 Jan; 23(11):1431-1435. PubMed ID: 33274871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between serum indirect bilirubin and prostate volume in patients with benign prostatic hyperplasia: a cross-sectional study.
    Ling C; Wu X; Huang W; Pang A; Wu Y; Wang X; Zhang C; Tian Y
    Ann Transl Med; 2022 Oct; 10(20):1127. PubMed ID: 36388836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Waist circumference is an independent risk factor for prostatic hyperplasia in Taiwanese males.
    Wang HH; Hsieh CJ; Lin KJ; Chu SH; Chuang CK; Chen HW; Hsieh ML; Wang TM; Chen Y; Liu KL; Huang HC; Hsu YC; Chiang YJ
    Asian J Surg; 2011 Oct; 34(4):163-7. PubMed ID: 22464832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum sex hormones and measures of benign prostatic hyperplasia.
    Roberts RO; Jacobson DJ; Rhodes T; Klee GG; Leiber MM; Jacobsen SJ
    Prostate; 2004 Oct; 61(2):124-31. PubMed ID: 15305335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High serum concentration of estradiol may be a risk factor of prostate enlargement in aging male in China.
    Xu D; Wu Y; Shen H; Qian S; Qi J
    Aging Male; 2020 Mar; 23(1):1-6. PubMed ID: 29912660
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia.
    Marberger M; Roehrborn CG; Marks LS; Wilson T; Rittmaster RS
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1323-8. PubMed ID: 16434455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia.
    Hammarsten J; Högstedt B
    Blood Press; 1999; 8(1):29-36. PubMed ID: 10412880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relation between benign prostatic hyperplasia and obesity and estrogen].
    Matsuda T; Abe H; Suda K
    Rinsho Byori; 2004 Apr; 52(4):291-4. PubMed ID: 15164594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia.
    Roehrborn CG; Lee M; Meehan A; Waldstreicher J;
    Urology; 2003 Nov; 62(5):894-9. PubMed ID: 14624915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
    Lee JH; Kwon H; Park YW
    Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the clinical parameters of benign prostate hyperplasia in diabetic and non diabetic patients.
    Ozcan L; Besiroglu H; Dursun M; Polat EC; Otunctemur A; Ozbek E
    Arch Ital Urol Androl; 2017 Mar; 89(1):26-30. PubMed ID: 28403591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.